OQROGet OQRO Pro
Insider trade

Exelixis (EXEL)Director sold ~$887K

Julie Smith, Director at Exelixis, sold ~$887K of Exelixis shares.

~$887K
Approx. value · 20K sh @ $44.30
21K
Holds after · shares reported
Traded
Feb 18, 2026
Filed
Feb 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 11, 2026Company filing · Form 8-K · ResultsReported its results
  2. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
  3. Feb 13, 2026Insider · 3 peopleInsiders: 4 sales (~$3.0M)
  4. Feb 17, 2026Insider · 3 peopleInsiders: 4 sales (~$6.1M)
  5. Feb 18, 2026 · this disclosureInsiderDirector sold ~$887K of EXEL shares in the open market

What came next

  1. Feb 18, 2026Insider · 3 peopleInsiders: 3 sales (~$7.2M)
  2. Feb 19, 2026InsiderOfficer sold ~$1.32M of EXEL shares in the open market
  3. Feb 24, 2026InsiderOfficer sold ~$2.13M of EXEL shares in the open market
  4. May 5, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  5. May 7, 2026Insider · 3 peopleInsiders: 3 sales (~$4.1M)
  6. May 18, 2026Insider · 2 peopleInsiders: 2 sales (~$2.1M)
  7. May 20, 2026Insider · 6 days before an 8-KOfficer sold ~$1.6M of EXEL shares in the open market
  8. May 26, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 26, 2026, at the 2026 Annual Meeting of Stockholders (the Annual Meeting) of Exelixis, Inc. (Exelixis), Exelixis’ stockholders, upon recommendation of Exelixis’ Board of Directors, approved the amendment and restatement of the Exelixis, Inc. 2017 Equity Incentive Plan (as so amended and restated, the 2017 Plan).”
  9. May 26, 2026InsiderOfficer sold ~$2.19M of EXEL shares in the open market
  10. Jun 1, 2026Insider · 2 peopleInsiders: 2 sales (~$690K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Exelixis

For Exelixis, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 9 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EXEL page.

Other recent filings by Julie Smith, Director

The full history of Julie Smith, Director is on the profile page.

How this filing works

Other disclosures at Exelixis

Everything OQRO holds on this company is on its EXEL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data